Home > Press > Nanomix Receives Patent for Sensation Detection Technology
Devices harness unique features enabled by nanoelectronics resulting in ultra-sensitive, accurate and selective measurement of chemicals and bio molecules
Nanomix Receives Patent for Sensation Detection Technology
May 24, 2005
Nanomix Incorporated, a leading nanotechnology company commercializing nanoelectronic detection devices for industrial and biomedical applications, announced today the issuance of a U.S. patent for its nanostructured detection platform known as Sensation.
The patent includes broad claims related to nanostructured detection devices. These devices harness unique features enabled by nanoelectronics resulting in ultra-sensitive, accurate and selective measurement of chemicals and bio molecules. The devices have extremely low power requirements and are scalable for mass production in a variety of product applications.
"We are pleased with our emerging patent portfolio related to nanoelectronic detection, which supports our primary business focus," said David Macdonald, President and CEO of Nanomix. "These advancements open up a wide range of applications and commercial opportunities. As the first company to bring a nanoelectronic product to market, we are excited to be at the leading edge of this promising industry. In addition to our own products, we are currently pursuing a number of collaborations for the commercial deployment of Sensation technology."
This patent (US Patent No. 6,894,359, issued May 17, 2005) is the first to be issued in Nanomix' growing portfolio of pending patent applications for the Sensation detection platform and its industrial and biomedical uses. This follows the issuance of three previous patents related to Nanomix' hydrogen storage technology.
Nanomix is a leading nanotechnology company launching a menu of devices based on Sensation™ detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistry and silicon. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanotechnology - low power consumption, small size, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information.
Toll Free: 877.Nanomix (877.626.6649)
Copyright © Nanomix
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
MEMS & Sensors Technology Showcase: Finalists Announced for MEMS Executive Congress US 2014 October 23rd, 2014
Journal Nanotechnology Progress International (JONPI), 2014, Volume 5, Issue 1, pp 1-24 October 22nd, 2014
Imaging electric charge propagating along microbial nanowires October 20th, 2014
Graphenea opens US branch October 16th, 2014
Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014
QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014
Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014
Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014
Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014
Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014
Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014
harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014